Mitali is a medical device and pharmaceutical executive with over 25 years of diverse experience spanning injectables, implantables, infusion and injection drug delivery devices. She has a successful track record of developing, industrializing and commercializing medical devices and combination products. Mitali is currently the VP and Global Head of the Medical Device Development unit at Sanofi. Prior to that she worked at companies such as Becton Dickinson, where she and her team were instrumental in developing and launching the first terminally sterilized prefilled syringe used for maintaining patency of VADs; as well as at Bristol Myers Squibb, where she established BMS’ device strategy, process, governance, quality system, and team structure to operationalize that strategy, leading to the launch of BMS’ first drug-device combination product. Mitali is a Biomedical Engineer by academic training, is six sigma green belt certified, and has several issued patents.

Dr. Jon Bloom is a board-certified physician and entrepreneur with over 20 years of experience in technology development, patient monitoring, biomedical research, and health care delivery. He co-founded Podimetrics in 2011 while a student at the MIT Sloan School of Management, and he’s served as our CEO ever since. Dr. Bloom was first inspired to create a solution to help prevent diabetic amputations while practicing anesthesia; he frequently treated patients who required foot amputations and knew there had to be a less drastic way to prevent diabetic foot complications. He previously served as a Clinical Assistant Professor and staff anesthesiologist at the University of Pittsburgh Medical Center, and as the Director of Global Medical Affairs for Covidien’s Respiratory and Monitoring Solutions division. Dr. Bloom has co-authored more than 20 peer-reviewed publications with a primary focus on health care economics and perioperative complications. He earned his medical degree from the University of Pittsburgh School of Medicine and completed his residency at Massachusetts General Hospital. 

Lisa leads the Corporate Environmental, Social and Governance (ESG) strategy at Insulet, developing innovative new business models and ecosystems to sustain positive global impact. She has held Executive roles in Sustainability and CSR in Supply Chain Operations at Cisco, Dell Technologies, and EMC Corporation. Prior roles include IT portfolio management, internal consulting and leadership positions at Massachusetts General Hospital and Washington University School of Medicine, including consulting to the World Health Organization.

Antonio Sanchez-Cordero is a global healthcare private equity investor at Archimed, where he specializes in identifying and nurturing strategic investment opportunities in the medical devices and diagnostics sectors. With a robust background in corporate leadership, Antonio has held key roles at leading healthcare multinationals such as Thermo Fisher Scientific, Becton Dickinson and Werfen, focusing on business development, corporate strategy, and M&A.

Anthony is a Senior Vice President on ML Strategies’ federal advocacy team in Washington, DC. He works with clients to develop and implement effective messaging and legislative strategy. Anthony helps clients navigate the Congress and administration in pursuit of policy objectives and federal funding, as well as through congressional inquiries.

For well over a decade, Anthony has been working with Congress, the bureaucracy, and the media to advance client interests. He has represented major multi-national corporations, start-ups, non-profit organizations, industry coalitions, and labor unions from most major sectors of the economy. Anthony works extensively in health care, both reimbursement and regulation. He also represents clients in transportation, infrastructure, defense, technology, and manufacturing on issues including taxation, trade, and federal appropriations.

Prior to joining ML Strategies, Anthony served in government affairs and public relations roles at firms in Washington and Boston. He is active in Democratic politics, particularly in his home state of Massachusetts.

Michael is the Vice President of Healthcare Economics and Reimbursement for AtriCure, a surgical medical device company focused on treatment of atrial fibrillation.  Michael has responsibility for overall reimbursement, health economics, and market access strategy. Some of his groups work and collaboration with specialty societies has resulted in new CPT and MS-DRG payment codes.  Prior to his role at AtriCure he held leadership positions at Boston Scientific, Philips Healthcare, and Medtronic.

He earned his PhD at the University Florida in Applied Physiology.

Diana Gelston is the chief commercial officer of Best Buy Health for Best Buy Co. Inc. In her role, she is responsible for building and strengthening the company’s commercial relationships that aim to enable care at home for everyone.

Diana leads a large, diverse team in creating and executing high-impact, go-to-market strategies that support the company’s mission to enrich and save lives through technology and meaningful connections. At Best Buy Health, she is focused on developing integrated commercial strategies that support consumers wherever they are on their health journey and improve the care-at-home experience.

Previously, Diana has successfully launched and developed more than a dozen sales and marketing teams, with P&L’s of more than $2.1B, in tech, medical devices, digital health, and healthcare information systems at Amazon Business Healthcare, Fresenius Medical Care, Philips Healthcare, and other innovative start-ups.

Diana earned a bachelor’s degree from the University of Southern California and a certificate in Leadership Development and Business Administration from the University of Pennsylvania’s Wharton Business School.

Maureen Halligan is the Vice President of Advisory & Innovation Services at Cambridge Consultants, where she leads programs to define and delivery medical technology innovations. Maureen has over 10 years of experience in applying human-centered design approaches to identify unmet needs, translate these needs into product requirements, and implement solutions that meet requirements and promote an optimal user experience. She has worked on a myriad of medical technologies, with a focus in surgical innovations and digital health solutions. She holds a BS in Biomedical Engineering from the University of Virginia and an MS in Human Factors Engineering from Tufts University, where she previously taught Human Factors in Product Design. Maureen is a mother of two, and is passionate about creating mechanisms, communities, and innovations to better support women throughout and beyond the maternal care continuum.

Mary Anne Heino has served as a Director since August 2015, and became the Chairperson of our Board, the Chairperson of the Finance and Strategy Committee and a member of the Science and Technology Committee on March 1, 2024. She previously served as our Chief Executive Officer, a position she held from August 2015 until March 1, 2024, as our President and Chief Executive Officer, a position she held from August 2015 until March 2023, as our Chief Operating Officer, a position she held from March 2015 until August 2015, and as our Chief Commercial Officer, a position she held from April 2013 (when she joined the Company) until March 2015. Ms. Heino brings more than 30 years of diverse pharmaceutical industry experience to the Board. Prior to joining Lantheus, Ms. Heino held executive level roles at Angelini Labopharm LLC and Labopharm USA from February 2007 to March 2012. From May 2000 until February 2007, Ms. Heino served in numerous capacities at Centocor, Inc., a Johnson & Johnson (“J&J”) company. Ms. Heino began her professional career with Janssen Pharmaceutica, another J&J company, in June 1989 and held increasing roles in Sales and Marketing through 1999. Ms. Heino received her Master in Business Administration from the Stern School of Business at New York University. She earned a Bachelor of Science in Nursing from the City University of New York and a Bachelor’s of Science in Biology from the State University of New York at Stony Brook. Ms. Heino currently serves on the Executive Committee of the Massachusetts Business Roundtable and the Board of MassMEDIC.

Brian Johnson was named president of the Massachusetts Medical Device Industry Council (MassMEDIC) in July 2018. An accomplished author, media entrepreneur, Brian serves as the  association’s second chief executive officer in its history, managing its day-to-day operations and working with medical device industry executives in developing its policy agenda. Since its establishment in 1996, MassMEDIC has grown to 300 member companies – manufacturers and developers of medical products, suppliers, research institutions and academic health centers –  and has advanced the public policy interests of the New England medical device sector on Capitol Hill, Beacon Hill, and before various federal agencies. 

In 2007, Brian conceived and later launched MassDevice.com, where he been responsible for the strategic vision of the company, from inception through the summer of 2018, including leading the company through an acquisition in 2015 by WTWH Media.     

As publisher, Brian spearheaded the growth of MassDevice from 0 to 100,000+ readers each month and led the company to profitability in just 3 years and more than $2.8M in annual sales. In 2011, Brian conceived and launched DeviceTalks, a live-interview series featuring leaders in medicine. The event, which is held three times annually in Boston, Minnesota and Orange County, California, has attracted thousands of medical device executives to date and featured leaders from some of the world’s largest medical technology companies. Since 2015, Brian also founded and launched two additional magazines, Medical Design & Outsourcing and Drug Delivery Business News, bringing total readership under his supervision to over 1.5 million.  

Under Brian’s direction, MassDevice and its associated properties were widely recognized for its commitment to quality journalism. The editorial boards of the New York Times, NPR, Wall Street Journal, Washington Post have cited MassDevice’s coverage of issues pertaining to the medical device industry.  In 2012, MassDevice won a prestigious Communicator award in 2012 for excellence with its live web video series “Disruptors.”  

An experienced reporter and author, Brian has worked for The Associated Press, Boston Globe digital and The Eagle-Tribune newspaper, covering business and economics, local government and crime.  In 2017, his critically acclaimed first novel “MWD: Hell is Coming Home” was released by Candlewick Press. 

Brian resides in Brookline, Massachusetts with his wife and two young children.  

​

​

Justin Kelly currently serves as Noctrix Health’s Senior Vice President, Patient Access where he oversees market access strategy, government relations and reimbursement operations. Justin joined Noctrix Health in June 2023. Prior to joining Noctrix Health, Justin had extensive experience launching novel therapies and medical devices leading reimbursement and market access functions at Novocure, Sirtex Medical, Insulet Corporation and Genzyme Biosurgery. He holds a Master’s Degree in Global Business Administration from the Fletcher School at Tufts University as well as a Bachelor’s of Science in Nursing from the University of Massachusetts.

 Michael Minogue is the President and CEO of Minogue Consulting, LLC. and Heartwork Capital, with over 30 years of industry experience leading with his “Patients First” and “Dream Big, Execute Bigger” mindset. By training individuals how to adapt, execute, lead, and manage, Michael empowers and inspires people to achieve their best results with integrity, creativity, intellect, and grit. 

For nearly 19 years, Michael served as Chairman, President, and CEO of Abiomed, Inc. (NASDAQ: ABMD), which revolutionized the field of heart recovery through the development of Impella®, the world’s smallest heart pumps. He devoted himself and the company to recovering hearts and saving lives, leading in technology and innovation, growing shareholder value, and sustaining a winning culture. This culture and vision led Abiomed, Inc. to be one of the fastest growing, GAAP profitable MedTech companies, generating total shareholder return of 2,467% since April 2004 and 1,172% in the last 10 years. 

Under Michael’s leadership from 2004-2022, Abiomed, Inc. treated over 250,000 patients, received multiple exclusive FDA approvals, expanded their patent portfolio to over 2,000 patents and over 2,000 pending, increased revenue from $22M to $1.2B, and grew market capitalization from $170M to approximately $17B. His tenure culminated in negotiating with Johnson & Johnson, resulting in the largest all-cash acquisition in MedTech history (16.9x EV/Revenue | 64.4x EV/EBITDA) and the 7th largest MedTech deal of all time. 

Prior to Abiomed, Inc., Michael spent 11 years with General Electric Healthcare, leading in roles of sales, marketing, product development, engineering, software, and services. While there, Michael filed three patents. He also served as an Infantry officer in the U.S. Army, where he earned multiple distinctions including Airborne, Ranger, and Bronze Star as the lead navigator and Platoon Leader for the 24th Infantry division in Desert Storm. Michael received his B.S. in Engineering Management from the United States Military Academy at West Point and his M.B.A. from the University of Chicago. 

Michael currently serves on the boards of Insulet Corporation (NASDAQ: PODD), St. John’s Preparatory School, Crane Estate Advisory Board, and MedTechVets. In addition, Michael is a co-owner of BOOST Oxygen and serves as General Partner for Essex Woodlands. Previously, Michael served on the board of the medical device industry association, Advamed (2007-2023) and as Chairman (2021-23). He has also served on the boards of LifeCell, Bioventus, and Medical Device Innovation Consortium, (MDIC, Chair-2016-19). 

Michael is passionate about supporting education, military veterans and causes for children. In 2012, Michael co-founded MedTechVets, a 501(c)(3) nonprofit organization that helps military veterans discover career opportunities in MedTech. In 2015, he co-founded the Mike and Renee Minogue Foundation to support faith-based education and pediatric care through partnerships with the Catholic Schools Foundation, WonderFund, Boston Children’s Hospital, and multiple others. 

Michael is married with five children and enjoys reading, running, coaching, and skiing. 

Joe Mullings has been building companies and careers since 1989. He is the Founder, Chairman and CEO of The Mullings Group, including TMG Search and Dragonfly. The search firm, with over three decades in the industry, is responsible for more than 9,000 successful searches in medtech / healthtech / life sciences with clients ranging from multi-billion-dollar companies to emerging high-tech organizations worldwide. TMG’s international presence and work with over 900 companies allow them to provide solutions to the clients they partner with across the globe.

As the first search firm to integrate media and talent access, Dragonfly was launched as a media production company, complete with a state-of-the-art studio, for use by clients and partners for attention and awareness. Dragonfly is the media machine behind the 7-time Telly Award winning video docuseries, “TrueFuture,” of which Joe is the host. He is also the founder of TMGPulse, a MedTech news and opinion website.

Joe is an active member of the medtech and investor community. He sits on industry boards and serves as an adviser to many emerging tech startups and technology accelerators as well as being an angel investor. He holds an engineering degree from The University of Dayton, Ohio.

A high-energy, connection-driven, non-profit executive, with a background in life sciences, technology and robotics engineering, Rachel joined MassMEDIC as Vice President in February 2020. During her tenure, the organization has tripled its headcount and increased its operating budget by more than 40%. Rachel joined the organization just weeks before the COVID-19 pandemic shut down all in-person events, and pivoted its in-person events strategy, launching a virtual events campaign to serve members and keep the medtech community connected.   

Promoted to Chief Operating Officer of MassMEDIC in 2021, Rachel is responsible for executing the organization’s strategy, including cultivating community partnerships and employee development.  She guides the direction and execution of the organizations programming and community collaborations, including Think Tanks on patient engagement, Working Groups around digital health, and she leads the MassMEDIC’s IGNITE Accelerator Program.    

As President of MassMEDIC IGNITE, one of medtech’s most successful accelerators, it has been her honor to help women- and minority-led ventures, raise more than $100M in the past two years. Their goal, and hers, is to drastically improve how medicine is practiced and challenge the standard of care.  

Rachel has spent the last 15 years in life sciences, primarily focusing on promotion of this important industry through business development and marketing. Through roles at Delve, Acorn Product Development and MPR, her skills have been centered on developing new strategic relationships, growing teams, and initiating thought leadership initiatives to drive awareness.  

​

​

Kate Rumrill is President and CEO of Ablative Solutions, a clinical stage company developing the Peregrine System, an alcohol mediated renal denervation product, for the treatment of hypertension. A seasoned professional. with over 30 years of pharmaceutical and medical device experience, Kate brings a wealth of knowledge and insights to the MassMedic Board.  She began her career as a Toxicologist with companies such as Sterling Winthrop and Eli Lilly & Company. She later transitioned to focus on clinical research, holding various roles over the years, from CRA to VP. Most recently, Kate was the President and CEO of NeoSync, Inc., a clinical stage company, developing novel non-invasive neuromodulation devices in the CNS space. Prior to that, she held the position of Vice President, Global Medical Affairs with Covidien’s Peripheral Vascular Division. She has extensive experience in product development and new product launches, most notably through her time at Covidien and Eli Lilly & Company.

Holly is Vice President and a Senior Partner at The Mullings Group, and has been a part of the firm for 25+ years. She believes the most productive and fulfilling organizations are built on the complementary forces that make up a team. Her bidirectional approach to each search allows her to put the best interest of both the individual and the company at the center of her team’s work. She is passionate about the medical device industry, which works to elevate health and healthcare, the individual careers we help build, and the team at TMG. These individuals keep Holly committed to being better every day.

Continuously giving back to the industry, Holly is a member, guest speaker, and advocate for MassMEDIC’s Women in Medtech organization. She also hosts two podcasts, The Power Curve, and Tech Talks with Holly Scott.

Holly is a graduate of the University of Florida with a psychology major and a business minor. She has also been awarded Certified Senior Account Manager (CSAM) by MRINetwork, an international network of recruiting firms.